BiotechTubeBiotechTube
Home/Arvinas/Ian Taylor
IT

Ian Taylor

Executive Vice President and Chief Scientific Officer

Arvinas

Therapeutic Areas

OncologyNeurology

Arvinas Pipeline

DrugIndicationPhase
Vepdegestrant (ARV-471)ER+/HER2- Advanced Breast CancerPhase 3
Bavdegalutamide (ARV-110)Prostate CancerPhase 2
ARV-766Prostate CancerPhase 2
ARV-102Parkinson's DiseasePhase 1
ARV-393LymphomaPhase 1
ARV-6723Solid MalignanciesPhase 1
ARV-806Pancreatic CancerPhase 1
ARV-027Breast CancerPhase 1

Leadership Team at Arvinas

JG
John G. Houston
President, Chief Executive Officer, and Chairperson of the Board
RM
Ronald M. Peck
Executive Vice President and Chief Medical Officer
SA
Sean A. Cassidy
Executive Vice President, Chief Financial Officer, and Treasurer
SA
Sunil Agarwal
Executive Vice President, Head of Therapeutics Development and Chief Development Officer
CM
Craig M. Crews
Founder, Professor at Yale University, Executive Director of Yale Center for Molecular Discovery
View full Arvinas profile